MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from warrant
exercise-Warrant Inducement
$8,719,353
Proceeds from public
offering,...
$3,388,244
Proceeds from warrant
exercise-Class HCommon Stock...
$363,000
Proceeds from warrant
exercise-Class HPre Funded...
$297
Net cash provided by
financing activities
$12,470,894
Net increase
(decrease) in cash and cash...
$4,201,313
Canceled cashflow
$8,269,581
Stock-based compensation
expense
$595,368
Accrued expenses
$269,756
Depreciation expense
$27,058
Non-cash lease expense
$18,630
Loss on disposal of
equipment
-$11,207
Operating lease liability
$5,866
Net cash used in
operating activities
-$8,269,581
Canceled cashflow
$927,885
Net loss
-$8,913,649
Accounts payable
-$206,120
Prepaid expenses and
other current assets
$44,598
Other assets
$30,941
Change in fair value of
warrant liability
-$2,158
Back
Back
Cash Flow
source: myfinsight.com
REVELATION BIOSCIENCES, INC. (REVBW)
REVELATION BIOSCIENCES, INC. (REVBW)